A carregar...

Medical management of inflammatory bowel disease among Canadian gastroenterologists

BACKGROUND: Little is known about physician perceptions of and practices in using infliximab – a biological agent that was approved in Canada for the treatment of Crohn’s disease in 2001, and for ulcerative colitis in 2006. OBJECTIVES: To describe Canadian gastroenterologists’ use and perceptions of...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Jones, J, Panaccione, R, Russell, ML, Hilsden, R
Formato: Artigo
Idioma:Inglês
Publicado em: Pulsus Group Inc 2011
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3206553/
https://ncbi.nlm.nih.gov/pubmed/22059162
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!